7-30785874-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032222.3(MINDY4):āc.545T>Cā(p.Ile182Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_032222.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MINDY4 | NM_032222.3 | c.545T>C | p.Ile182Thr | missense_variant | 4/18 | ENST00000265299.6 | NP_115598.2 | |
INMT-MINDY4 | NR_037598.1 | n.1074T>C | non_coding_transcript_exon_variant | 6/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MINDY4 | ENST00000265299.6 | c.545T>C | p.Ile182Thr | missense_variant | 4/18 | 1 | NM_032222.3 | ENSP00000265299.6 | ||
INMT-MINDY4 | ENST00000458257.5 | n.*632T>C | non_coding_transcript_exon_variant | 6/20 | 2 | ENSP00000456039.1 | ||||
INMT-MINDY4 | ENST00000458257.5 | n.*632T>C | 3_prime_UTR_variant | 6/20 | 2 | ENSP00000456039.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000152 AC: 38AN: 249560Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135388
GnomAD4 exome AF: 0.000175 AC: 256AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000160 AC XY: 116AN XY: 727248
GnomAD4 genome AF: 0.000112 AC: 17AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74336
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at